Toxicity of hydroxychloroquine, a potential treatment for COVID-19, on free-living marine nematodes

Mar Pollut Bull. 2021 Jun:167:112361. doi: 10.1016/j.marpolbul.2021.112361. Epub 2021 Apr 15.

Abstract

On March 2020, hydroxychloroquine (HCQ) was recommended as a treatment for COVID-19 high risk patients. Following the massive and widespread use of HCQ worldwide, a discernible high quantity is anticipated to end-up through the sewage systems in marine coastal areas. A closed microcosm study was undertaken herein for 30 days where meiobenthic nematodes were exposed to a range of HCQ concentrations (3.162, 31.62 and 63.24 μg.ml-1). After one month of exposure in HCQ, the total abundances and Shannon-Wiener index of the assemblages decreased, whereas the individual mass and the Trophic Diversity Index increased at the highest concentrations. Overall, a numerical negative impact was observed for the epistrate feeders and non-selective deposit feeders, however, this benefited to the omnivores-carnivores, and particularly to the Oncholaimids. Such responses of the nematodes 2B and the corresponding taxa are bioindicative of current- or post-COVID-19 crisis risks in relation with the bioaccumulation of HCQ in seafood.

Keywords: COVID-19 crisis; Ecotoxicity; Free-living marine nematodes; Hydroxychloroquine; Seafood.

MeSH terms

  • Animals
  • COVID-19 Drug Treatment*
  • Humans
  • Hydroxychloroquine / toxicity
  • Nematoda*
  • SARS-CoV-2

Substances

  • Hydroxychloroquine